219 related articles for article (PubMed ID: 14573669)
1. Human phagocytic cell responses to Scedosporium apiospermum (Pseudallescheria boydii): variable susceptibility to oxidative injury.
Gil-Lamaignere C; Roilides E; Lyman CA; Simitsopoulou M; Stergiopoulou T; Maloukou A; Walsh TJ
Infect Immun; 2003 Nov; 71(11):6472-8. PubMed ID: 14573669
[TBL] [Abstract][Full Text] [Related]
2. Antifungal triazoles and polymorphonuclear leukocytes synergize to cause increased hyphal damage to Scedosporium prolificans and Scedosporium apiospermum.
Gil-Lamaignere C; Roilides E; Mosquera J; Maloukou A; Walsh TJ
Antimicrob Agents Chemother; 2002 Jul; 46(7):2234-7. PubMed ID: 12069979
[TBL] [Abstract][Full Text] [Related]
3. Human phagocytic cell responses to Scedosporium prolificans.
Gil-Lamaignere C; Maloukou A; Rodriguez-Tudela JL; Roilides E
Med Mycol; 2001 Apr; 39(2):169-75. PubMed ID: 11346264
[TBL] [Abstract][Full Text] [Related]
4. Identification of Scedosporium boydii catalase A1 gene, a reactive oxygen species detoxification factor highly expressed in response to oxidative stress and phagocytic cells.
Mina S; Staerck C; d'Almeida SM; Marot A; Delneste Y; Calenda A; Tabiasco J; Bouchara JP; Fleury MJJ
Fungal Biol; 2015 Dec; 119(12):1322-1333. PubMed ID: 26615753
[TBL] [Abstract][Full Text] [Related]
5. Inteferon gamma and granulocyte-macrophage colony-stimulating factor augment the antifungal activity of human polymorphonuclear leukocytes against Scedosporium spp.: comparison with Aspergillus spp.
Gil-Lamaignere C; Winn RM; Simitsopoulou M; Maloukou A; Walsh TJ; Roilides E
Med Mycol; 2005 May; 43(3):253-60. PubMed ID: 16010852
[TBL] [Abstract][Full Text] [Related]
6. Amphotericin B lipid complex exerts additive antifungal activity in combination with polymorphonuclear leucocytes against Scedosporium prolificans and Scedosporium apiospermum.
Gil-Lamaignere C; Roilides E; Maloukou A; Georgopoulou I; Petrikkos G; Walsh TJ
J Antimicrob Chemother; 2002 Dec; 50(6):1027-30. PubMed ID: 12461027
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of Pseudallescheria boydii and Scedosporium apiospermum to new antifungal agents.
Zeng J; Kamei K; Zheng Y; Nishimura K
Nihon Ishinkin Gakkai Zasshi; 2004; 45(2):101-4. PubMed ID: 15118667
[TBL] [Abstract][Full Text] [Related]
8. Effects of interleukin-15 on antifungal responses of human polymorphonuclear leukocytes against Fusarium spp. and Scedosporium spp.
Winn RM; Gil-Lamaignere C; Roilides E; Simitsopoulou M; Lyman CA; Maloukou A; Walsh TJ
Cytokine; 2005 Jul; 31(1):1-8. PubMed ID: 15935692
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor alpha enhances antifungal activities of polymorphonuclear and mononuclear phagocytes against Aspergillus fumigatus.
Roilides E; Dimitriadou-Georgiadou A; Sein T; Kadiltsoglou I; Walsh TJ
Infect Immun; 1998 Dec; 66(12):5999-6003. PubMed ID: 9826384
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamic and immunological interactions of amphotericin B formulations and voriconazole with human neutrophils against mature Scedosporium apiospermum and Fusarium spp. biofilms.
Vikelouda K; Simitsopoulou M; Antachopoulos C; Skoura L; Roilides E
J Antimicrob Chemother; 2023 Apr; 78(4):1076-1083. PubMed ID: 36848199
[TBL] [Abstract][Full Text] [Related]
11. Amphotericin B formulations variably enhance antifungal activity of human neutrophils and monocytes against Fusarium solani: comparison with Aspergillus fumigatus.
Dotis J; Simitsopoulou M; Dalakiouridou M; Konstantinou T; Panteliadis C; Walsh TJ; Roilides E
J Antimicrob Chemother; 2008 Apr; 61(4):810-7. PubMed ID: 18272514
[TBL] [Abstract][Full Text] [Related]
12. Effects of lipid formulations of amphotericin B on activity of human monocytes against Aspergillus fumigatus.
Dotis J; Simitsopoulou M; Dalakiouridou M; Konstantinou T; Taparkou A; Kanakoudi-Tsakalidou F; Walsh TJ; Roilides E
Antimicrob Agents Chemother; 2006 Mar; 50(3):868-73. PubMed ID: 16495244
[TBL] [Abstract][Full Text] [Related]
13. Antifungal activity of human polymorphonuclear and mononuclear phagocytes against non-fumigatus Aspergillus species.
Akpogheneta O; Gil-Lamaignere C; Maloukou A; Roilides E;
Mycoses; 2003 Apr; 46(3-4):77-83. PubMed ID: 12870194
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Scedosporium apiospermum glucosylceramides and their involvement in fungal development and macrophage functions.
Rollin-Pinheiro R; Liporagi-Lopes LC; de Meirelles JV; Souza LM; Barreto-Bergter E
PLoS One; 2014; 9(5):e98149. PubMed ID: 24878570
[TBL] [Abstract][Full Text] [Related]
15. Scedosporium apiospermum keratitis treated with itraconazole.
Saracli MA; Erdem U; Gonlum A; Yildiran ST
Med Mycol; 2003 Apr; 41(2):111-4. PubMed ID: 12964842
[TBL] [Abstract][Full Text] [Related]
16. Scedosporium apiospermum fungemia in a lung transplant recipient.
Raj R; Frost AE
Chest; 2002 May; 121(5):1714-6. PubMed ID: 12006471
[TBL] [Abstract][Full Text] [Related]
17. Pathology of hyalohyphomycosis caused by Scedosporium apiospermum (Pseudallescheria boydii): an emerging mycosis.
Tadros TS; Workowski KA; Siegel RJ; Hunter S; Schwartz DA
Hum Pathol; 1998 Nov; 29(11):1266-72. PubMed ID: 9824105
[TBL] [Abstract][Full Text] [Related]
18. Susceptibility and diversity in the therapy-refractory genus scedosporium.
Lackner M; Hagen F; Meis JF; Gerrits van den Ende AH; Vu D; Robert V; Fritz J; Moussa TA; de Hoog GS
Antimicrob Agents Chemother; 2014 Oct; 58(10):5877-85. PubMed ID: 25070092
[TBL] [Abstract][Full Text] [Related]
19. Pulmonary Scedosporium apiospermum Infection with Pulmonary Tumorlet in an Immunocompetent Patient.
Motokawa N; Miyazaki T; Hara A; Fukuda Y; Morino S; Nakamura H; Iwasaki K; Soda H; Izumikawa K; Yanagihara K; Ohno H; Miyazaki Y; Kohno S; Mukae H
Intern Med; 2018 Dec; 57(23):3485-3490. PubMed ID: 30101932
[TBL] [Abstract][Full Text] [Related]
20. Comparative in-vitro activity of voriconazole (UK-109,496) and six other antifungal agents against clinical isolates of Scedosporium prolificans and Scedosporium apiospermum.
Cuenca-Estrella M; Ruiz-Díez B; Martínez-Suárez JV; Monzón A; Rodríguez-Tudela JL
J Antimicrob Chemother; 1999 Jan; 43(1):149-51. PubMed ID: 10381115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
